热门资讯> 正文

AC Immune首席执行官Andrea Pfeifer将在23年后退休

2026-05-12 20:15

AC Immune (ACIU) on Tuesday said co-founder and CEO Andrea Pfeifer will retire at the company’s upcoming annual general meeting after leading the neurodegenerative disease drug developer for 23 years.
Board Chair Martin Zügel will take over as interim CEO while the company searches for a permanent successor.
Pfeifer will remain involved as an advisor, honorary chair of the board, and co-chair of the scientific advisory board.

More on AC Immune

AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts
AC Immune rises after amending licensing deal with Lilly
AC Immune says partner J&J pauses enrollment in mid-stage trial for Alzheimer’s drug
Seeking Alpha’s Quant Rating on AC Immune
Historical earnings data for AC Immune

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。